Search

Search Constraints

You searched for: Author/Creator Alcolea, Daniel

Search Results

1. 1H‐MRS signature in Alzheimer disease in Down syndrome: Neuroimaging / Optimal neuroimaging measures for tracking disease progression. (7th December 2020)

2. [O1–06–02]: BIPHASIC MODEL IN PRECLINICAL ALZHEIMER's DISEASE: AV45 PET, CSF TAU AND CORTICAL THICKNESS. (1st July 2017)

3. [O3–10–03]: LONGITUDINAL CEREBROSPINAL FLUID BIOMARKER TRAJECTORIES ALONG THE ALZHEIMER'S DISEASE CONTINUUM: A MULTICENTRE EUROPEAN STUDY. (1st July 2017)

4. [P1–238]: THE SAPPβ/YKL‐40 RATIO IN CEREBROSPINAL FLUID AS A DIAGNOSTIC MARKER IN FRONTOTEMPORAL LOBAR DEGENERATION: A PATHOLOGICAL STUDY. (1st July 2017)

5. [P1–366]: WEIGHT LOSS MIGHT BE A NON‐COGNITIVE SIGN OF PRECLINICAL ALZHEIMER'S DISEASE. (1st July 2017)

6. [P2–259]: NETWORK ANALYSIS OF THE CSF PROTEOME IDENTIFIES SYNAPTIC PROTEINS OF HIPPOCAMPAL ORIGIN AS PUTATIVE BIOMARKERS FOR AD‐RELATED SYNAPSE LOSS. (1st July 2017)

7. [P3–274]: STRUCTURAL CORRELATES OF ALZHEIMER's DISEASE AND AGING IN DOWN SYNDROME: AN MRI STUDY. (1st July 2017)

8. [P4–505]: CORTICAL MICROSTRUCTURAL CHANGES IN FRONTOTEMPORAL LOBAR DEGENERATION: A NEW IMAGING BIOMARKER. (1st July 2017)

9. A metabolite‐based machine learning approach to diagnose Alzheimer‐type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort. Issue 1 (1st January 2019)

10. A multimodal study on the effect of sex on Alzheimer's disease clinical and biomarker changes in adults with Down syndrome. (31st December 2021)